74046-07-4,
(S)-4-aminohex-5-enoic acid,
(S)-Vigabatrin,
S(+)-4-Aminohexenoic acid,
(S)-(+)-Vigabatrin,
UNII-0S931RNJ68,
S-(+)-Vigabatrin,
(S)-4-Amino-5-hexenoic Acid,
S(+)-|A-Vigabatrin,
RMI 71890,
(+)-|A-Vinyl GABA,
(S)-4-Aminohex-5-enic acid,
(4S)-4-Amino-5-hexenoic Acid,
0S931RNJ68,
(+)-gamma-Vinyl GABA,
S(+)--Vigabatrin,
5-Hexenoic acid, 4-amino-, (+)-,
S(+)-gamma-Vinyl GABA,
S(+)-gamma-Vinyl-GABA,
S(+)-|A-Vinyl GABA,
SCHEMBL465981,
4(S)-Amino-5-hexenoic Acid,
S(+)-gamma-Vigabatrin, solid,
S(+)-| pound-VIGABATRIN,
CTK8D4124,
DTXSID80224944,
PJDFLNIOAUIZSL-RXMQYKEDSA-N,
BCP09861,
KS-000010VG,
ZINC3798750,
BN0802,
FCH841084,
MFCD00274076,
AKOS006275524,
5-Hexenoic acid, 4-amino-, (4S)-,
API0010200,
AJ-45644,
SC-91570,
TC-071793,
FT-0675812,
I14-13195,
UNII-GR120KRT6K component PJDFLNIOAUIZSL-RXMQYKEDSA-N,
vigabatrin,
Vigabatrin, (S)-,
C6-H11-N-O2,
CID10219440,
60643-86-9,